use pseudomonas aeruginosa vaccine pateints acute leukemia cystic fibrosis heptavalent lipopolysaccharide pseudomonas vaccine evaluated 22 patient acute leukemia 12 patient cystic fibrosis 18 month interval clinical center national institute health 34 patient 32 excellent serum hemagglutinating ha antibody response immunization comparison patient cystic fibrosis patient leukemia smaller ha antibody response lasted shorter period time alsoi experienced greater toxicity vaccine mixing adrenal corticosteroid vaccine greatly decreased side reaction among patient leukemia without significantly inhibiting antibody production previous antineoplastic chemotherapy little influence antibody response patient leukemia exception methortrexate vaccinated patient leukemia 1 pseudomonas infection 14 bacterial fungal infection whereas 2 pseudomonas infection 5 bacterial fungal infection occurred control group 20 patient acute leukemia 12 patient cystic fibrosis 4 pseudomonas infection vaccination